KMT2A
Universal Cellular Machinery · Chromatin Remodeling & Epigenetic Regulation
What does KMT2A add to the proteins that package DNA?
KMT2A encodes a regulator with histone-methylating activity. These chromatin marks help control gene programs used in early development and blood-cell formation.
- Common Gene Name
- lysine methyltransferase 2A
- NCBI Gene ID
- 4297
- Chromosome
- 11
Clinical Evidence Status
Established disease relationshipTumor or drug-label biomarker context
These labels describe available evidence about a gene. They do not classify your variant or recommend a treatment.
Answer Sources
Explore supporting evidence (3 records)
| Condition or drug | Evidence | Grade / status | Context | Source |
|---|---|---|---|---|
| Wiedemann-Steiner syndrome | ClinGen gene-disease validity | Definitive | Autosomal dominant | View source 2022-05-22 |
| Revumenib (2) | FDA labeling biomarker | Label mentions biomarker; actionability not inferred | Oncology | View source |
| Ziftomenib (2) | FDA labeling biomarker | Label mentions biomarker; actionability not inferred | Oncology | View source |
Source snapshot: 2026-09-09. Consumer text updated: 2026-09-10. Source dates describe the cited records, not a new clinical review.
← Back to Universal Cellular Machinery